UK markets closed
  • NIKKEI 225

    29,098.24
    -7.77 (-0.03%)
     
  • HANG SENG

    25,628.74
    -409.53 (-1.57%)
     
  • CRUDE OIL

    82.33
    -2.32 (-2.74%)
     
  • GOLD FUTURES

    1,797.60
    +4.20 (+0.23%)
     
  • DOW

    35,547.30
    -209.58 (-0.59%)
     
  • BTC-GBP

    42,497.20
    -3,037.86 (-6.67%)
     
  • CMC Crypto 200

    1,405.23
    -69.10 (-4.69%)
     
  • ^IXIC

    15,267.35
    +31.63 (+0.21%)
     
  • ^FTAS

    4,138.68
    -11.13 (-0.27%)
     

Insights on the Post Operative Nausea and Vomiting Global Market to 2027 - Featuring Novartis, Acacia Pharma and Sanofi Among Others - ResearchAndMarkets.com

·3-min read

DUBLIN, September 28, 2021--(BUSINESS WIRE)--The "Post Operative Nausea and Vomiting Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.

The report on the global post operative nausea and vomiting market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global post operative nausea and vomiting market to grow with a CAGR of 8.38% over the forecast period from 2021-2027. The study on post operative nausea and vomiting market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on post operative nausea and vomiting market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global post operative nausea and vomiting market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global post operative nausea and vomiting market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Segment Covered

The global post operative nausea and vomiting market is segmented on the basis of treatment type, and distribution channel.

The Global Post Operative Nausea and Vomiting Market by Treatment Type

  • Serotonin Antagonists

  • Dopamine Antagonists

  • NK-1 Receptor Antagonists

  • Non-pharmacological Treatment

The Global Post Operative Nausea and Vomiting Market by Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies & Drug Stores

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the post operative nausea and vomiting market.

2. Complete coverage of all the segments in the post operative nausea and vomiting market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global post operative nausea and vomiting market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Market Dynamics

Drivers

  • Growing adoption rate of combination therapies as well as non-pharmacological treatment modes

Restraints

  • Strict regulatory approvals and high health care expenditure

Opportunities

  • Launch of newer therapies

Company Profiles

  • Novartis AG

  • Acacia Pharma

  • Hoffmann-La Roche AG

  • Camurus AB

  • Sanofi S.A

  • Helsinn Holding S.A

  • Eisai Corporation

  • Merck and Co

  • GlaxoSmithKline Corporation

For more information about this report visit https://www.researchandmarkets.com/r/heivd1

View source version on businesswire.com: https://www.businesswire.com/news/home/20210928005515/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting